Similar results were obtained in a study in mice, in which steatosis associated with the development of non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD) was accompanied by a reduction in the activity of antioxidant enzymes, including catalase, in hepatocytes [70]. The gene discussed is CAT; the disease is metabolic dysfunction-associated steatohepatitis.